Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...
Ayble Health’s Series A round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic ...
Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.
The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.
Ultragenyx Pharmaceutical’s Fayuvi is now the first FDA-approved therapy for the underlying cause of Sanfilippo syndrome type ...
As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional ...
Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView ...
Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst ...
Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration ...
Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health ...
Nara Health’s funding was led by Khosla Ventures, with participation from Long Journey Ventures and Superior Studios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results